Avery Dennison Corp. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated January 29, 2020, serves as a current report for Avery Dennison Corporation. The filing references preliminary, unaudited financial results for the fourth quarter and full year 2019, along with guidance for the 2020 fiscal year. Detailed financial data is contained in attached Exhibits 99.1 (Press Release) and 99.2 (Supplemental Presentation), which are furnished but not filed as part of this specific document text.
Key Financial Metrics
The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached exhibits and the company's investor website. The filing confirms the registration of Common Stock (AVY) and 1.25% Senior Notes due 2025 (AVY25) on the New York Stock Exchange.
Material Changes
No specific material changes in financial performance or position are quantified within the body of this filing. The report indicates that a webcast and teleconference were held on January 29, 2020, to discuss these results, implying that the detailed analysis of changes versus prior periods is located in the referenced exhibits.
Guidance, Outlook, and Risks
The filing includes a "Safe Harbor" statement regarding forward-looking statements and guidance for the 2020 fiscal year found in the exhibits. Management identified the following significant risk factors that could affect near-term financial performance:
- Impacts to underlying demand and foreign currency fluctuations due to global economic conditions and political uncertainty.
- Competitor actions regarding pricing, market expansion, and product offerings.
- The ability to offset higher costs through productivity measures or price increases without losing volume.
- Execution and integration of acquisitions.
Additional risks cited include raw material cost fluctuations, customer concentration, cyber-security threats, tax law changes, and the impact of epidemiological events.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures for Q4 and Full Year 2019 in Exhibit 99.1.
- Review the detailed 2020 fiscal year guidance provided in the supplemental presentation (Exhibit 99.2).
- Confirm the status of the 1.25% Senior Notes due 2025 and any recent debt refinancing activities.
- Assess the impact of foreign currency fluctuations on reported margins as discussed in the management commentary.
- Monitor the integration progress of recent acquisitions mentioned as a key risk factor.